References
- Debbag R. Dr. Hugó Rene Paganini (1959–2010). Rev. Chil. Infect.28(Suppl. 1), S7–S8 (2011).
- Vacchino MN. Incidence of hepatitis A in Argentina after vaccination. J. Viral Hepat.15(Suppl. 2), S47–S50 (2008).
- Centers for disease control and prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the advisory committee on immunization practices, 2010. MMWR Morb. Mortal. Wkly Rep.60(1), 13–15 (2011).
- Sáfadi MA, Cintra OA. Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention. Neurol. Res.32(3), 263–271 (2010).
- Chacón-Cruz E, Martínez-Longoria CA, Llausas-Magaña E et al. Red nacional para enfermedad meningocóccica y meningitis en México: resultados preliminares a un año de establecida la vigilancia activa en 10 hospitales. Presented at: XIV Congreso Latinoamericano de Infectología Pediátrica (SLIPE). Punta Cana, República, Dominicana, 25–28 May 2011 (Abstract Vac-12).
- Richardson V, Hernandez-Pichardo J, Quintanar-Solares M et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N. Engl. J. Med.362(4), 299–305 (2010).
- Sáfadi MA, Berezin EN, Munford V et al. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil. Pediatr. Infect. Dis. J.29(11), 1019–1022 (2010).
- Yen C, Armero Guardado JA, Alberto P et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr. Infect. Dis. J.30(Suppl. 1), S6–S10 (2011).
- Molto Y, Cortes JE, De Oliveira LH et al. Reduction of diarrhea-associated hospitalizations among children aged <5 years in Panama following the introduction of rotavirus vaccine. Pediatr. Infect. Dis. J.30(Suppl. 1), S16–S20 (2011).
- Quian J, Rüttimann R, Romero C et al. Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997–2005. Arch. Dis. Child.93(10), 845–850 (2008).
- Shieh WJ, Blau DM, Denison AM et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am. J. Pathol.177(1), 166–175 (2010).
- Simonsen L, Taylor RJ, Young-Xu Y, Haber M, May L, Klugman KP. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio2(1), e00309–e00310 (2011).
- Páfadi MC, Algorta G, Cedrés A et al. Impact of universal pneumococcal vaccination on hospitalizations for pneumonia and meningitis in children in Montevideo, Uruguay. Pediatr. Infect. Dis. J.30(8), 669–674 (2011).
- Tregnaghi MW, Sáez-Llorens X, López P et al. Evaluating the efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) against community-acquired pneumonia in Latin America. Presented at: 29th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID). The Hague, The Netherlands, 7–11 June 2011 (Abstract 1411).
- Salas-Peraza D, Avila-Agüero ML, Morice-Trejos A. Switching from OPV to IPV: are we behind the schedule in Latin America? Expert Rev. Vaccines9(5), 475–483 (2010).
- San Martín JL, Brathwaite O, Zambrano B et al. The epidemiology of dengue in the Americas over the last three decades: a worrisome reality. Am. J. Trop. Med. Hyg.82(1), 128–135 (2010).
- Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH. Economic impact of dengue illness in the Americas. Am. J. Trop. Med. Hyg.84(2), 200–207 (2011).
Websites
- SLIPE website (Sociedad Latinoamericana de Infectología Pediátrica). www.slipe.org/drCalil/1_semblanzaDrCalil.pdf
- ACIP Provisional Recommendations. www.cdc.gov/vaccines/recs/provisional/default.htm